Yonghe Medical Group Co (FRA:L97) Altman Z2-Score: 1.58 (As of Aug. 21, 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:L97 Yonghe Medical Group Co Ltd FRA:L97
84 GF Score
Price €0.26
GF Value €0.21
! 7 Warning Signs
View Full Analysis

What is Yonghe Medical Group Co Altman Z2-Score?

Yonghe Medical Group Co FRA:L97 -1.53% 84 Altman Z2-Score is 1.58 as of Aug. 21, 2026, which is 7% above its 10-year median of 1.47. GuruFocus rates FRA:L97 with a GF Score™ of 84/100 and a GF Value™ of €0.21. The stock has 7 warning signs investors should review. Among 638 Healthcare Providers & Services companies, Yonghe Medical Group Co ranks worse than 55.96% on this metric.

Altman Z2-Score, also known as Z"-Score, is used to predict the likelihood that a non-manufacturing company (excluding property/financial company) will face bankruptcy within a two-year period.

Yonghe Medical Group Co has a Altman Z2-Score of 1.58, indicating it is in Grey Zones. This implies that Yonghe Medical Group Co is in some kind of financial stress. If it is below 1.1, the company may face bankrupcy risk.

The zones of discrimination were as such:

When Altman Z2-Score <= 1.1, it is in Distress Zones.
When Altman Z2-Score >= 2.6, it is in Safe Zones.
When Altman Z2-Score is between 1.1 and 2.6, it is in Grey Zones.

The historical rank and industry rank for Yonghe Medical Group Co's Altman Z2-Score or its related term are showing as below:

FRA:L97' s Altman Z2-Score Range Over the Past 10 Years
Min: -1.06   Med: 1.47   Max: 4.12
Current: 1.58

During the past 8 years, Yonghe Medical Group Co's highest Altman Z2-Score was 4.12. The lowest was -1.06. And the median was 1.47.


Yonghe Medical Group Co  (FRA:L97) Altman Z2-Score Explanation

The original Z-Score model was based on publicly traded manufacturing companies while the Z2-Score, also known as Z"-score can be used for any type of company excluding property/financial companies. Both Z-Score and Z2-Score describes the financial health of a company, and its likelihood of financial distress.

X1: The Working Capital/Total Assets (WC/TA) ratio is a measure of the net liquid assets of the firm relative to the total capitalization. Working capital is defined as the difference between current assets and current liabilities. Ordinarily, a firm experiencing consistent operating losses will have shrinking current assets in relation to total assets. Altman found this one proved to be the most valuable liquidity ratio comparing with the current ratio and the quick ratio. This is however the least significant of the five factors.

X2: Retained Earnings/Total Assets: the RE/TA ratio measures the leverage of a firm. Retained earnings is the account which reports the total amount of reinvested earnings and/or losses of a firm over its entire life. Those firms with high RE, relative to TA, have financed their assets through retention of profits and have not utilized as much debt.

X3, Earnings Before Interest and Taxes/Total Assets (EBIT/TA): This ratio is a measure of the true productivity of the firm's assets, independent of any tax or leverage factors. Since a firm's ultimate existence is based on the earning power of its assets, this ratio appears to be particularly appropriate for studies dealing with corporate failure. This ratio continually outperforms other profitability measures, including cash flow.

X4_2, Net Worth (Total Stockholders Equity - Preferred Stock)/Total Liabilities (NW/TL): it compares a company’s stock net worth with its total liabilities and can be used to assess the extent of its reliance on debt.

Read more about Altman Z2-Score, the original research on Z-Score and the additional research on Z2-Score.


Be Aware

Altman Z2-Score does not apply to financial companies.


Yonghe Medical Group Co Altman Z2-Score Related Terms


Yonghe Medical Group Co Altman Z2-Score Historical Data

* Premium members only.

The historical data trend for Yonghe Medical Group Co's Altman Z2-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Yonghe Medical Group Co Altman Z2-Score Chart

Yonghe Medical Group Co Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Altman Z2-Score
Get a 7-Day Free Trial 4.12 2.85 -1.06 -0.90 1.58

Yonghe Medical Group Co Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25 Jun26
Altman Z2-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 -0.90 0.00 1.58 0.00

FRA:L97 vs HCA, THC, DVA: Altman Z2-Score Comparison

For the Medical Care Facilities subindustry, Yonghe Medical Group Co's Altman Z2-Score, along with its competitors' market caps and Altman Z2-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Yonghe Medical Group Co Altman Z2-Score vs Healthcare Providers & Services Industry

For the Healthcare Providers & Services industry and Healthcare sector, Yonghe Medical Group Co's Altman Z2-Score distribution charts can be found below:

* The bar in red indicates where Yonghe Medical Group Co's Altman Z2-Score falls into.


FRA:L97
84GF Score
Yonghe Medical Group Co Ltd FRA:L97
Altman Z2-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Yonghe Medical Group Co Altman Z2-Score Calculation

Altman Z-Score model is an accurate forecaster of failure up to two years prior to distress. It can be considered the assessment of the distress of industrial corporations.

Z2-Score, also known as Z"-Score is the Z-Score for non-manufacturing companies excluding property/financial companies.

Yonghe Medical Group Co's Altman Z2-Score for today is calculated with this formula:

Z=6.56*X1+3.26*X2+6.72*X3+1.05*X4_2
=6.56*0.1787+3.26*-0.307+6.72*0.0755+1.05*0.8618
=1.58

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency. GuruFocus does not calculate Altman Z2-Score when X4_2 value is 0.

Trailing Twelve Months (TTM) ended in Dec. 2025:
Total Assets was €206.4 Mil.
Total Current Assets was €103.5 Mil.
Total Current Liabilities was €66.6 Mil.
Retained Earnings was €-63.4 Mil.
Pre-Tax Income was €12.8 Mil.
Interest Expense was €-2.8 Mil.
Total Liabilities was €110.9 Mil.

* Note that for stock reported semi-annually or annually, GuruFocus uses latest annual data as the TTM data.

X1=Working Capital/Total Assets
=(Total Current Assets - Total Current Liabilities)/Total Assets
=(103.489 - 66.604)/206.351
=0.1787

X2=Retained Earnings/Total Assets
=-63.35/206.351
=-0.307

X3=Earnings Before Interest and Taxes/Total Assets
=(Pre-Tax Income - Interest Expense)/Total Assets
=(12.786 - -2.792)/206.351
=0.0755

X4_2=Net Worth/Total Liabilities
=(Total Stockholders Equity - Preferred Stock)/Total Liabilities
=(95.553 - 0)/110.881
=0.8618

The zones of discrimination were as such:

Distress Zones - 1.1 < Grey Zones < 2.6 - Safe Zones

Yonghe Medical Group Co has a Altman Z2-Score of 1.58 indicating it is in Grey Zones.

Frequently Asked Questions Learn more about Altman Z2-Score →
What does a Altman Z2-Score of 1.58 mean?
Yonghe Medical Group Co (FRA:L97) has a Altman Z2-Score of 1.58 as of Aug. 21, 2026. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Yonghe Medical Group Co and its competitors. This is near median its historical median of 1.47. According to the industry distribution chart, Yonghe Medical Group Co ranks #357 out of 638 companies in the Healthcare Providers & Services industry, placing it in the top 56%.
Is Yonghe Medical Group Co's Altman Z2-Score too high?
Yonghe Medical Group Co's current Altman Z2-Score of 1.58 is near median its 10-year median of 1.47. The Healthcare Providers & Services industry median Altman Z2-Score is 2.08. Yonghe Medical Group Co's value of 1.58 is 24% below this industry median. Based on the distribution chart, Yonghe Medical Group Co ranks #357 out of 638 companies in the Healthcare Providers & Services industry, which is below the industry midpoint. Overall, Yonghe Medical Group Co has a GF Score™ of 84/100, reflecting its overall financial health beyond just this single metric.
How does Yonghe Medical Group Co's Altman Z2-Score compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Yonghe Medical Group Co ranks #357 out of 638 companies for Altman Z2-Score. This places Yonghe Medical Group Co in the lower half of its industry. The industry median Altman Z2-Score is 2.08. Yonghe Medical Group Co's value of 1.58 is 24% below this benchmark. While the company's 10-year median is 1.47 vs. the industry median of 2.08, Yonghe Medical Group Co has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Altman Z2-Score for a Healthcare Providers & Services company?
The median Altman Z2-Score among Healthcare Providers & Services companies is 2.08, based on 638 companies in the industry. Companies in the top quartile (top 25%) have a Altman Z2-Score significantly above this median, while those in the bottom quartile fall well below. However, Altman Z2-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Yonghe Medical Group Co's current Altman Z2-Score of 1.58 is 24% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Altman Z2-Score mean?
A high Altman Z2-Score can signal that a stock is expensive relative to its fundamentals. Z2-Score is the Z-Score for non-manufacturing companies excluding property/financial companies, which measures a company's bankruptcy risk. View historical data on Yonghe Medical Group Co and its competitors. For the Healthcare Providers & Services industry, the median Altman Z2-Score is 2.08 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Yonghe Medical Group Co's current Altman Z2-Score is 1.58, which is near median its own 10-year median of 1.47. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Yonghe Medical Group Co stock overvalued right now?
Yonghe Medical Group Co (FRA:L97) has a current Altman Z2-Score of 1.58. The stock's GF Value™ is €0.21, compared to a current price of €0.26 — trading 22.9% above its estimated fair value. The current Altman Z2-Score is 1.58, which is near median its 10-year median of 1.47 and 24% below the Healthcare Providers & Services industry median of 2.08. Yonghe Medical Group Co's overall GF Score™ is 84/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Altman Z2-Score calculated?
Altman Z2-Score is calculated from a company's financial statements. For Yonghe Medical Group Co (FRA:L97), the current Altman Z2-Score is 1.58 as of Aug. 21, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Yonghe Medical Group Co (FRA:L97) Overvalued in 2026?

Based on GuruFocus' analysis, Yonghe Medical Group Co stock appears to be overvalued. The current stock price of €0.26 is trading 22.9% above its estimated GF Value™ of €0.21.

Key valuation signals for FRA:L97:

  • Altman Z2-Score: 1.58 (near median its 10-year median of 1.47)
  • GF Value™: €0.21 vs. price of €0.26 (22.9% above fair value)
  • GF Score™: 84/100 with 7 warning signs
  • Industry Position: 24% below the Healthcare Providers & Services median (#357 of 638)

No single metric tells the full story. See the FRA:L97 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Yonghe Medical Group Co Business Description

Other Exchanges 02279:Hong Kong
Address Office Tower No. 12B, Chaowai Street, 16th Floor, KunTai International Building, Chaoyang District, Beijing, CHN, 100020
Yonghe Medical Group Co Ltd is a medical group in China that specializes in providing hair-related healthcare services. The company is principally engaged in the provision of hair transplant services. The company generated the majority of its revenue from hair transplant services. The company offers one-stop hair-related healthcare services covering hair transplants, medical hair care, routine hair restoration, and other ancillary services.
84GF Score

Get the complete analysis for FRA:L97

Altman Z2-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.26
Price
€0.21
GF Value